Document is current
Any future updates will be listed below
-
Authors
Li, Guangye
Chen, Guo
Yuan, Guo-Hua https://orcid.org/0000-0002-8459-3784
Wei, Jia
Ni, Qingyang https://orcid.org/0009-0001-7727-4080
Wu, Jing
Yang, Bei https://orcid.org/0000-0001-5389-3859
Yang, Li https://orcid.org/0000-0001-8833-7473
Chen, Jia https://orcid.org/0000-0002-4242-2899
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology of the People's Republic of China (2023YFC3403402, 2024YFA1803301, 2023ZD0500501, 2024YFC3405902)
Ministry of Agriculture and Rural Affairs of the People's Republic of China (NK2022010207)
Science and Technology Commission of Shanghai Municipality (23XD1422500, 23ZR1442500, 23DX1900102, 23JS1400300)
National Natural Science Foundation of China (32371514, 32070170, 32430018)
- License Information
-
More Information
Article History
Received: 6 May 2024
Accepted: 13 February 2025
First Online: 26 March 2025
Competing interests
: J.C., L.Y. and B.Y. are scientific cofounders of CorrectSequence Therapeutics, a company that uses gene-editing technologies, and the members of its scientific advisory board. J.C., L.Y., B.Y., G.L. and G.C. have filed patent applications relating to the published work through ShanghaiTech University. The remaining authors declare no competing interests.
